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Introduction
Antimicrobial resistance (AMR) represents a significant
global threat. It is useful to estimate the economic bur-
den of AMR as these represent potential cost savings
from reducing the problem.
Objectives
To determine the impact of antimicrobial resistance on
cost attributable to bloodstream infections (BSIs) caused
by Staphylococcus aureus and Enterobacteriaceae from a
European hospital perspective.
Methods
We performed a multicentre retrospective cohort study
including acute inpatient episodes at ten European hospitals
in 2010 and 2011. BSIs were the time-varying exposure of
interest, with S. aureus classified as methicillin-susceptible
(MSSA) or resistant (MRSA), and Enterobacteriaceae as
third-generation-cephalosporin-susceptible (3GCSE) or
resistant (3GCRE). We used multistate models to estimate
excess length-of-stay (LOS). For each bacteria/susceptibility
combination, we computed the attributable cost of a single
BSI as the product of excess LOS and the bed-day value.
We used two contrasting bed-day values: an economic
value obtained by contingent valuation and the accounting
cost derived by dividing the annual hospital budget by the
number of bed-days. To estimate the annual hospital costs
of each BSI, these BSI costs were multiplied by the expected
number of BSI cases per year. We performed a probabilistic
sensitivity analysis to account for parameter uncertainty.
Results
Our cohort included 606,649 patients. Third-generation-
cephalosporin-resistance significantly increased the
hazard of death (1.5 [1.0–2.2]), excess LOS (4.9 [1.1–8.7])
and cost compared to susceptible strains, whereas methi-
cillin resistance did not. Whilst 3GCSE BSI was asso-
ciated with the lowest per-infection cost (€320 [95%
credible interval, €80–€1,300] or €4,000 [€2,400–€6,700]
using economic and accounting valuations, respectively),
their relative frequency resulted in equal highest annual
cost with MSSA (€77,000 [€19,000–€300,000] or
€970,000 [€590,000–€1,600,000] using economic and
accounting valuations, respectively).
Conclusion
While BSI with S. aureus has a greater impact on mor-
tality, excess LOS and cost than Enterobacteriaceae per
infection, the impact of antimicrobial resistance is
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